TAK-901
Cat.No:IT1640 Solarbio
CAS:934541-31-8
Molecular Formula:C28H32N4O3S
Molecular Weight:504.66
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Off-white to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Cell Cycle >
TAK-901CAS:934541-31-8
Molecular Formula:C28H32N4O3S
Molecular Weight:504.66
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Off-white to yellow Solid
Qty:
Size:
CAS | 934541-31-8 |
Name | TAK-901 |
Molecular Formula | C28H32N4O3S |
Molecular Weight | 504.66 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | Off-white to yellow Solid |
Storage | Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
SMILES | O=C(NC1CCN(CC1)C)C2=C(C3=C(C4=CC(C)=CN=C4N3)C(C5=CC=CC(S(=O)(CC)=O)=C5)=C2)C |
Target Point | CLK2;JAK3;FGR;c-Src;YES1;Aurora Kinase; |
Passage | Cell Cycle |
Background | TAK-901 is a multi-targeted Aurora inhibitor. |
Biological Activity | TAK-901是多靶点的的极光激酶 (aurora)抑制剂,对极光激酶A和B的IC50 值分别为21 和15 nM。[1] |
IC50 | Aurora A:21nM;Aurora B:15nM [1] |
Data Literature Source | [1]. Farrell P,et al. Biological characterization of TAK-901,an investigational,novel,multitargeted Aurora B kinase inhibitor. Mol Cancer Ther. 2013 Apr;12(4):460-70. |
Unit | Bottle |
Specification | 5mg 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.